Filing Flows

Filing Flows › Amneal Pharmaceuticals (AMRX) › Who owns the stock

Who owns Amneal Pharmaceuticals (AMRX) stock

297 funds reported Amneal Pharmaceuticals (AMRX) shares in their latest 13F filings, worth $3.0B in all. The largest holder is BlackRock ($460M). Last quarter 166 funds added to their stakes and 121 cut them.

Largest holders of AMRX (13F)Largest holders of AMRX (13F)BlackRock$460MVanguard Group$226MTPG GP A, LLC$213MVanguard Portfolio Management LLC$210MRubric Capital Management LP$176MVanguard Capital Management LLC$133MState Street$127MDimensional Fund Advisors LP$100MGeode Capital Management, LLC$89.0MNantahala Capital Management, LLC$78.5M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock26,562,093$460Mincrease2026-06-30
Vanguard Group17,907,815$226Mdecrease2025-12-31
TPG GP A, LLC12,328,767$213Munchanged2026-06-30
Vanguard Portfolio Management LLC12,137,727$210Mincrease2026-06-30
Rubric Capital Management LP10,168,660$176Mdecrease2026-06-30
Vanguard Capital Management LLC7,710,126$133Mincrease2026-06-30
State Street7,356,977$127Mincrease2026-06-30
Dimensional Fund Advisors LP5,794,263$100Mincrease2026-06-30
Geode Capital Management, LLC5,139,449$89.0Mincrease2026-06-30
Nantahala Capital Management, LLC4,537,502$78.5Mincrease2026-06-30
Morgan Stanley4,110,028$71.1Mdecrease2026-06-30
Neuberger Berman Group LLC3,887,179$67.3Mincrease2026-06-30
Invesco3,502,000$60.6Mincrease2026-06-30
Nuveen, LLC3,324,875$57.6Mincrease2026-06-30
Allspring Global Investments Holdings, LLC3,295,533$55.9Mincrease2026-06-30

Amneal Pharmaceuticals' latest quarter

Amneal Pharmaceuticals, Q3 2026: revenue $863M (+10% year over year), operating margin 11.1%, net earnings $12.3M, operating cash flow $98.3M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most AMRX stock?

By the latest 13F filings: BlackRock ($460M); Vanguard Group ($226M); TPG GP A, LLC ($213M); Vanguard Portfolio Management LLC ($210M); Rubric Capital Management LP ($176M).

What is the short interest in AMRX?

14,067,810 shares were sold short at the 2026-10-15 settlement, 24.73% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.